These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 24167104)
1. Neuropathic pain in patients with sickle cell disease. Brandow AM; Farley RA; Panepinto JA Pediatr Blood Cancer; 2014 Mar; 61(3):512-7. PubMed ID: 24167104 [TBL] [Abstract][Full Text] [Related]
2. Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report. Román ME; Highland J; Retherford D; Pan AY; Panepinto JA; Brandow AM Pediatr Blood Cancer; 2020 Dec; 67(12):e28698. PubMed ID: 33034107 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of neuropathic pain in adolescents with sickle cell disease: A single-center experience. Cregan M; Puri L; Kang G; Anghelescu D Pediatr Blood Cancer; 2022 Apr; 69(4):e29583. PubMed ID: 35147289 [TBL] [Abstract][Full Text] [Related]
4. Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain? Ezenwa MO; Molokie RE; Wang ZJ; Yao Y; Suarez ML; Pullum C; Schlaeger JM; Fillingim RB; Wilkie DJ Pain Pract; 2016 Mar; 16(3):282-93. PubMed ID: 25581383 [TBL] [Abstract][Full Text] [Related]
5. Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults. Antunes FD; Propheta VGS; Vasconcelos HA; Cipolotti R Ann Hematol; 2017 Jul; 96(7):1121-1125. PubMed ID: 28361297 [TBL] [Abstract][Full Text] [Related]
6. Neuropathic pain in individuals with sickle cell disease. Sharma D; Brandow AM Neurosci Lett; 2020 Jan; 714():134445. PubMed ID: 31454562 [TBL] [Abstract][Full Text] [Related]
7. Screening for neuropathic pain in patients with sickle cell disease: is a single assessment scale sufficient? Antunes FD; Silva Junior CL; Cerqueira KS; do Livramento Faro M; Cipolotti R Orphanet J Rare Dis; 2019 May; 14(1):108. PubMed ID: 31088489 [TBL] [Abstract][Full Text] [Related]
8. Neuropathic Pain Screening: Construct Validity in Patients With Sickle Cell Disease. Powell-Roach K; Yao Y; Ezenwa MO; Schlaeger JM; Suarez ML; Molokie RE; Wang ZJ; Wilkie DJ West J Nurs Res; 2020 Feb; 42(2):125-130. PubMed ID: 30900520 [TBL] [Abstract][Full Text] [Related]
9. Neuropathic pain in sickle cell disease: measurement and management. Glaros A; Brandow AM Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):553-561. PubMed ID: 33275730 [TBL] [Abstract][Full Text] [Related]
10. Neuropathic Pain and Sickle Cell Disease: a Review of Pharmacologic Management. Orhurhu MS; Chu R; Claus L; Roberts J; Salisu B; Urits I; Orhurhu E; Viswanath O; Kaye AD; Kaye AJ; Orhurhu V Curr Pain Headache Rep; 2020 Jul; 24(9):52. PubMed ID: 32705357 [TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease. Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27896936 [TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life and neuropathic pain in sickle cell disease in Jamaica. Bartlett R; Ramsay Z; Ali A; Grant J; Rankine-Mullings A; Gordon-Strachan G; Asnani M Disabil Health J; 2021 Oct; 14(4):101107. PubMed ID: 33867318 [TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. Wilkie DJ; Molokie R; Boyd-Seal D; Suarez ML; Kim YO; Zong S; Wittert H; Zhao Z; Saunthararajah Y; Wang ZJ J Natl Med Assoc; 2010 Jan; 102(1):18-27. PubMed ID: 20158132 [TBL] [Abstract][Full Text] [Related]
14. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults. Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417 [TBL] [Abstract][Full Text] [Related]
15. The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay. Brandow AM; Farley RA; Dasgupta M; Hoffmann RG; Panepinto JA J Pediatr Hematol Oncol; 2015 Jan; 37(1):10-5. PubMed ID: 25222053 [TBL] [Abstract][Full Text] [Related]
17. Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature. Brandow AM; Farley RA; Panepinto JA Pediatr Blood Cancer; 2015 Sep; 62(9):1501-11. PubMed ID: 25976161 [TBL] [Abstract][Full Text] [Related]
18. Avoiding Catch-22: validating the PainDETECT in a in a population of patients with chronic pain. Timmerman H; Wolff AP; Bronkhorst EM; Wilder-Smith OHG; Schenkels MJ; van Dasselaar NT; Huygen FJPM; Steegers MAH; Vissers KCP BMC Neurol; 2018 Jun; 18(1):91. PubMed ID: 29958535 [TBL] [Abstract][Full Text] [Related]
19. Neurobiological mechanisms of pain in sickle cell disease. Wang ZJ; Wilkie DJ; Molokie R Hematology Am Soc Hematol Educ Program; 2010; 2010():403-8. PubMed ID: 21239826 [TBL] [Abstract][Full Text] [Related]
20. Do We Pay Enough Attention to Neuropathic Pain in Knee Osteoarthritis Patients? Golob M; Marković I; Zovko N; Šakić D; Gudelj-Gračanin A; Morović-Vergles J Acta Clin Croat; 2018 Mar; 57(1):16-21. PubMed ID: 30256007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]